# Pearls and Pitfalls of Revision Unilateral Biportal Endoscopic Lumbar Spine Surgery: A Technical Note

**Authors:** Jiawen Fong, Zi Xian Justin Chou, Walter-Soon-Yaw Wong, Yilun Huang

PMC · DOI: 10.7759/cureus.86958 · Cureus · 2025-06-29

## TL;DR

This paper introduces a new endoscopic surgical technique for revision lumbar spine surgery, highlighting its benefits over traditional methods.

## Contribution

The paper presents a novel revision unilateral biportal endoscopic lumbar spine surgery (RUBELSS) approach with detailed technical insights.

## Key findings

- RUBELSS offers improved visualization and reduced soft tissue disruption compared to traditional methods.
- The technique allows for faster operating times and better short-term outcomes in revision decompression.
- Key steps include MRI-based planning and meticulous decompression with anatomical landmark awareness.

## Abstract

We aim to describe our revision unilateral biportal endoscopic lumbar spine surgery (RUBELSS) approach, emphasising pre-operative planning, surgical technique, and management of complications. Key steps include utilising various endoscopic approaches based on the compression site, pre-operative magnetic resonance imaging (MRI) and radiograph analysis for surgical planning, and meticulous decompression with attention to anatomical landmarks. Additionally, potential complications like dural tears and intra-operative bleeding, as well as their bailout options, are discussed. Revision decompression for degenerative lumbar disease traditionally involves open or microscopic approaches. Endoscopic spine surgery (ESS) offers advantages over these approaches, including improved visualisation, reduced soft tissue disruption, and better short-term outcomes. Overall, RUBELSS presents a viable alternative for revision decompression, offering advantages over traditional techniques with superior short-term outcomes, faster operating times, and reduced complications.

## Full-text entities

- **Genes:** FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, F2 (coagulation factor II, thrombin) [NCBI Gene 2147] {aka PT, RPRGL2, THPH1}
- **Diseases:** spondylolisthesis (MESH:D013168), Dural tears (MESH:D020785), bleeding (MESH:D006470), vision loss (MESH:D014786), disc herniation (MESH:D007405), degenerative lumbar disease (MESH:D019636), postoperative pain (MESH:D010149), discogenic pain (MESH:D010146), complication (MESH:D008107), disease (MESH:D004194), hypertrophy (MESH:D006984), nerve injury (MESH:D000080902), pressure injuries (MESH:D003668), LDDD (MESH:D055959), lower back pain (MESH:D017116), weakness (MESH:D018908), infection (MESH:D007239)
- **Chemicals:** water (MESH:D014867)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12306511/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12306511/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12306511/full.md

---
Source: https://tomesphere.com/paper/PMC12306511